Inogen Inc. Shares Soar 13.81% on Revenue Growth

Inogen Inc. (INGN) shares surged 13.81% in pre-market trading on April 9, 2025, driven by a series of positive developments and strategic initiatives.

Inogen Inc. reported a 5.5% increase in Q4 revenue, highlighting the company's strong financial performance and growth trajectory. This revenue growth was supported by strategic partnerships and operational efficiencies, which have positioned Inogen for continued success in the healthcare sector.

The company's consensus rating remains at Hold, with an average rating score of 2.00. This rating is based on two hold ratings, indicating a cautious yet stable outlook from analysts. The average twelve-month price target for Inogen is $7.00, reflecting a balanced view of the company's future prospects.

Inogen's management team received a 3% base salary increase, reflecting the company's commitment to rewarding its executives for their contributions to its growth and success. This increase comes after a year without salary adjustments, underscoring the company's focus on long-term sustainability and employee satisfaction.